You are here

  • Home
  • Archive
  • Volume 18, Issue 6
  • Serous carcinoma of the uterus—determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation

Article metrics

Article menu
Download PDFPDF
ORIGINAL ARTICLE
Serous carcinoma of the uterus—determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 2019800
Apr 20191801
May 20191600
Jun 20191300
Jul 20192103
Aug 20192000
Sep 20191700
Oct 20192100
Nov 2019600
Dec 20191000
Jan 20201800
Feb 20202600
Mar 20201201
Apr 20201500
May 20202800
Jun 20203300
Jul 20201600
Aug 20201100
Sep 2020800
Oct 20201100
Nov 2020500
Dec 2020800
Jan 20211400
Feb 2021400
Mar 20211400
Apr 2021500
Jun 2021200
Aug 2021100
Sep 2021001
Oct 20211000
Nov 20211500
Dec 20211200
Jan 20222300
Feb 20221100
Mar 20222701
Apr 20222600
May 20223400
Jun 20224400
Jul 20222201
Aug 20224000
Sep 20229502
Oct 20222800
Nov 20221800
Dec 20221700
Jan 20233002
Feb 20237701
Mar 20231400
Apr 20232304
May 2023600
Jun 20235600
Jul 20231200
Aug 20231400
Sep 2023600
Oct 20231404
Nov 20231700
Dec 20232801
Jan 2024600
Feb 20242202
Mar 20241400
Apr 20241200
Total1154024